Coronary artery disease in patients with psoriasis referred for coronary angiography

April W Armstrong1, Caitlin T Harskamp, Lynda Ledo

  • 1Department of Dermatology, University of California Davis, Sacramento, USA. aprilarmstrong@post.harvard.edu

Insights

Psoriasis patients have a higher risk of coronary artery disease (CAD). This study found psoriasis is independently linked to CAD, especially when present for over 8 years, even after accounting for other risk factors.

Area of Science:

  • Cardiology
  • Dermatology
  • Epidemiology

Background:

  • Psoriasis is a chronic inflammatory disease.
  • Patients with psoriasis may face an elevated risk of cardiovascular disease (CVD), including myocardial infarction.
  • The association between psoriasis and coronary artery disease (CAD) independent of traditional CVD risk factors requires further investigation.

Purpose of the Study:

  • To determine if psoriasis is associated with a higher prevalence of CAD.
  • To assess if this association persists independently of established cardiovascular risk factors.
  • To examine the impact of psoriasis duration on CAD prevalence.

Main Methods:

  • Retrospective cohort analysis linking coronary angiography records (2004-2009) with dermatology records.
  • Identified 204 patients with psoriasis from a cohort of 9,473 patients undergoing coronary angiography.
  • Statistical analysis adjusted for established cardiovascular risk factors.

Main Results:

  • Patients with psoriasis showed a higher prevalence of CAD (84.3% vs 75.7%, p = 0.005).
  • Psoriasis was independently associated with angiographically confirmed CAD (adjusted odds ratio 1.8, p = 0.006).
  • Psoriasis duration exceeding 8 years was also independently linked to CAD (adjusted odds ratio 3.5, p = 0.02).

Conclusions:

  • Psoriasis is independently associated with a higher prevalence of CAD in patients undergoing coronary angiography.
  • Patients with psoriasis, particularly those with disease duration over 8 years, exhibit increased CAD prevalence.
  • These findings highlight the importance of cardiovascular risk assessment in psoriasis patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...